glp 1 causing anxiety Frontiers GLP-1 medications used to treat

Ipamorelin a selective ghrelin receptor agonist emerged from studies in the 1990s investigating ghrelin mimetics and their ability to stimulate growth hormone release with minimal off-target hormonal effects

As the native GLP-1 has a short half-life, GLP-1 analogues have been produced to prolong effects and many of them could cross blood-brain barriers (BBB) such as Liraglutide (LG), lixisenatide, and exendin-4

Parenthetical numbers indicate the Enzyme Commission designations corresponding to upregulated enzymes in the diagram

XULTOPHY [ZUL toh fye] pairs liraglutide with insulin degludec (Tresiba)

Dietary modifications including reducing sulphur-rich foods, eating smaller portions, and avoiding high-fat meals can minimise symptoms